The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.

Two professors are named Innovation Investigators, and four win Ignite Awards.

Physicians, researchers and other pacesetters describe some of the most promising pursuits in the medical field. In cancer, for instance: ‘Let’s kill the first cell, not the last cell.’…

New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.

Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.

The tumor suppressor p53 has been in the limelight for decades. But its cancer-fighting function may be only a side effect of its role in tissue repair, a Stanford Medicine study finds.

The Laurie K. Lacob Pavilion at the Stanford Medicine Cancer Center opened July 17. The state-of-the-art facility, for transplant and cellular therapies, is a light-filled space for healing.

Human cells evolving in the laboratory undergo a series of predictable, sequential genetic changes that lead to pre-cancer. Blocking these changes may allow intervention before cancer occurs.

An anticipated growth in veterans seeking cancer care catalyzes talks to develop state-of-the-art collaboration between VA and Stanford Medicine.

Cancer disproportionately impacts persistently impoverished communities. A federal grant unites Stanford Medicine, UC Davis and UCSF to study income supplementation and cancer risk factors.